These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 146766
1. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells. Berlinger NT, Hilal EY, Oettgen HF, Good RA. Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766 [Abstract] [Full Text] [Related]
2. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma. Maisel RH, Ogura JH. Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104 [No Abstract] [Full Text] [Related]
6. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Lutz CT, Kurago ZB. Cancer Res; 1999 Nov 15; 59(22):5793-9. PubMed ID: 10582701 [Abstract] [Full Text] [Related]
7. [Immune functions in cancers of the upper respiratory and digestive tracts]. Follézou JY, Bayssas M, Provost MA, Fridman WH, Dumont J, Point D, Brugère J. Nouv Presse Med; 1978 Oct 28; 7(37):3368. PubMed ID: 733515 [No Abstract] [Full Text] [Related]
8. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck]. Bulbuk GA. Vopr Onkol; 1982 Oct 28; 28(4):57-9. PubMed ID: 7090271 [Abstract] [Full Text] [Related]
11. Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer. Pierri I, Cordone G, Rogna S, Pende D, Garaventa G, Barabino A, Indiveri F. Cancer Detect Prev; 1984 Oct 28; 7(2):73-8. PubMed ID: 6231991 [Abstract] [Full Text] [Related]
12. Transference of cell mediated immunity in patients with head and neck cancer. Vetto RM, Burger DR. Laryngoscope; 1978 Jan 28; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143 [Abstract] [Full Text] [Related]
13. Detection and localization of tumor-associated immune components of head and neck squamous cell carcinomas. Popović D, Gill L, Sisson G, Applebaum E, Anderson B. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976 Jan 28; 82(2):119-30. PubMed ID: 59450 [No Abstract] [Full Text] [Related]
14. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status. Mussche RA, Plum J, de Smedt M, Kluyskens P. Acta Otorhinolaryngol Belg; 1977 Jan 28; 31(6):566-77. PubMed ID: 339662 [Abstract] [Full Text] [Related]
15. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)]. Niksić M, Balogh M. Laryngol Rhinol Otol (Stuttg); 1976 Nov 28; 55(11):882-7. PubMed ID: 136570 [Abstract] [Full Text] [Related]
16. Failure of cell-mediated effector mechanisms in lung cancer. Feo Figarella E, Morillo F, Blanca I, Bianco NE. J Natl Cancer Inst; 1984 Jul 28; 73(1):1-6. PubMed ID: 6330420 [Abstract] [Full Text] [Related]
17. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Spina CA, Dorey F, Vescera C, Brosman S, Fahey JL. Cancer Res; 1981 Nov 28; 41(11 Pt 1):4324-30. PubMed ID: 6458353 [Abstract] [Full Text] [Related]
18. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma. Wolf GT, Lovett EJ, Peterson KA, Beauchamp ML, Baker SR. Arch Otolaryngol; 1984 Nov 28; 110(11):731-5. PubMed ID: 6237633 [Abstract] [Full Text] [Related]
19. Evaluation of cell-mediated immunity in oral cancer patients. Rao RS, Fakih AR, Nair CN, Gangal SG, Naik SL. Indian J Cancer; 1984 Nov 28; 21(5-6):141-5. PubMed ID: 6336234 [No Abstract] [Full Text] [Related]
20. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes. Uchida A, Klein E. J Natl Cancer Inst; 1986 Mar 28; 76(3):389-98. PubMed ID: 2419621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]